Two Sigma Securities, LLC Curis Inc Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.57 - $0.99 $12,462 - $21,645	21,864 New	21,864 $18,000
Q4 2022 Feb 14, 2023	BUY	$0.47 - $17.22 $11,447 - $419,410	24,356 New	24,356 $13,000
Q2 2022 Aug 15, 2022	BUY	$0.71 - $2.43 $11,631 - $39,808	16,382 New	16,382 $16,000
Q3 2020 Nov 16, 2020	SELL	$0.95 - $1.42 $19,128 - $28,591	-20,135 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.63 - $1.7 $12,685 - $34,229	20,135 New	20,135 $24,000
Q1 2019 May 15, 2019	SELL	$0.78 - $2.01 $13,281 - $34,226	-17,028 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.62 - $2.25 $3,559 - $12,917	5,741 Added 50.86%	17,028 $12,000
Q3 2018 Nov 14, 2018	BUY	$1.38 - $1.94 $15,576 - $21,896	11,287 New	11,287 $20,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.